Consenting in cardiac surgery during COVID‐19: Are the risks quantifiable?

@article{Shafi2020ConsentingIC,
  title={Consenting in cardiac surgery during COVID‐19: Are the risks quantifiable?},
  author={A. Shafi and A. Harky},
  journal={Journal of Cardiac Surgery},
  year={2020},
  volume={35}
}
Coronavirus disease‐2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus 2 resulted in a global public health crisis and was declared a pandemic on the 21st of March 2020 by the WHO. With over 15 million confirmed cases and over 600 000 deaths, COVID‐19 is one of the worst medical crises of the 21st century. The unprecedented impact on healthcare systems with the sudden demand on resources, including critical care capacity, ventilators, and personal protective equipment… Expand
Congenital heart disease and incremental risks of COVID‐19
TLDR
This work aims to explore how COVID‐19 affects the CVS, with a focus on CHD and the risk these patients may be exposed to, as well as the changes made regarding consenting them for surgery. Expand
Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic
TLDR
Similar odds of adverse clinical outcomes was seen among patients undergoing CABG in the setting of COVID-19 compared with those in 2019, and the number of patients undergoing CABGs in 2020 has substantially declined compared to 2019. Expand
Early experience of aortic surgery during the COVID‐19 pandemic in the UK: A multicentre study
A significant restructuring of the healthcare services has taken place since the declaration of the coronavirus disease 2019 (COVID‐19) pandemic, with elective surgery put on hold to concentrateExpand
Advantages of, and Adaptations to, Enhanced Recovery Protocols for Perioperative Care during the COVID-19 Pandemic
TLDR
ERPs are evidence-based, best practice guidelines applied across the perioperative continuum to mitigate surgical stress, decrease complications, and accelerate recovery and are part of the high-value–care equation needed to solve the clinical, operational, and financial challenges of the current COVID-19 pandemic. Expand

References

SHOWING 1-10 OF 27 REFERENCES
Impact of COVID‐19 on cardiac surgical training: Our experience in the United Kingdom
TLDR
The impact COVID‐19 is having on cardiac surgical training in the UK and what future implications this may have is explored. Expand
The impact of COVID‐19 on the provision of cardiac surgical services
TLDR
Data is collected during this period to provide a good insight following the lockdown period and the effects on long‐term mortality and morbidity as well as financial implications on hospitals as a result of these changes. Expand
Adult Cardiac Surgery During the COVID-19 Pandemic: A Tiered Patient Triage Guidance Statement
Abstract In the setting of the current novel coronavirus pandemic, this document has been generated to provide guiding statements for the adult cardiac surgeon to consider in a rapidly evolvingExpand
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
TLDR
Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality, so thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Expand
Consent in the time of COVID-19
TLDR
It is argued that doctors should tailor information according to the needs of the individual patient, and require clinicians to be frank about limited resources and necessary rationing. Expand
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China
TLDR
The impact of the COVID-19 outbreak on STEMI care in Hong Kong is described through a handful of recent cases of patients with STEMI who underwent PPCI at a single center. Expand
Cardiac manifestations in COVID‐19 patients—A systematic review
TLDR
This work sought to systematically review the current published literature on the different cardiac manifestations and the use of cardiac‐specific biomarkers in terms of their prognostic value in determining clinical outcomes and correlation to disease severity. Expand
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
TLDR
Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Expand
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis
TLDR
Underlying disease, including hypertension, respiratory system disease and cardiovascular, may be a risk factor for severe patients compared with non-severe patients in COVID-19 infection patients. Expand
Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance From an International Cardiac Surgery Consortium
TLDR
This guidance document provides a framework for restarting cardiac surgery in the outpatient and inpatient settings, in accordance with the current understanding of SARS-CoV-2, the risks posed by interrupted cardiovascular care, and the available recommendations from major societies. Expand
...
1
2
3
...